Speaker illustration

Doctor Attila Borbely

University of Debrecen, Debrecen (Hungary)

Member of:

European Society of Cardiology
Heart Failure Association

Dr. Borbély graduated in 2002 from the University of Debrecen, Hungary, receiving his PhD in 2005. He became a cardiologist in 2010, an invasive cardiologist in 2015, and a heart failure (HF) specialist in 2021, endorsed by the British Society for Heart Failure. He visited the Department of Physiology in Amsterdam from 2003 to 2004 with a Marie Curie Fellowship and received a Basic Research Fellowship grant from the HFA of the ESC between 2008 and 2010, focusing on HFpEF cellular pathophysiology. Currently, Dr. Borbély is a staff cardiologist at the Institute of Cardiology, Debrecen. His research focuses on HF pathophysiology, effects of inodilators, myosin activators and inhibitors at the cellular level. He established the Heart Failure Outpatient Clinic in Debrecen and coordinates HF patient evaluation for heart transplantation/LVAD regionally. He is currently the president of the Working Group on Heart Failure and Myocardial Diseases of the Hungarian Society of Cardiology.

Chronic heart failure - pathophysiology and mechanisms 11

Event: Heart Failure 2024

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Moderated ePosters

Thumbnail

Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - Therapeutic options and clinical practice

Event: ESC Congress 2018

Topic: Treatment

Session type: Practical Tutorials

Thumbnail

Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - Therapeutic options and clinical practice

Event: ESC Congress 2018

Topic: Treatment

Session type: Practical Tutorials

Thumbnail